Acura Pharmaceuticals, Inc. (ACUR)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 12:40PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 198.00k |
| Enterprise Value | 333.00k |
| Trailing P/E | 7.00 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.11 |
| Price/Book (mrq) | 1.11 |
| Enterprise Value/Revenue | 0.21 |
| Enterprise Value/EBITDA | -0.57 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 49.26 |
| 52-Week Change 3 | -94.00% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 0.0500 |
| 52 Week Low 3 | 0.0001 |
| 50-Day Moving Average 3 | 0.0050 |
| 200-Day Moving Average 3 | 0.0017 |
Share Statistics
| Avg Vol (3 month) 3 | 1.05k |
| Avg Vol (10 day) 3 | 2.08k |
| Shares Outstanding 5 | 66M |
| Implied Shares Outstanding 6 | 66M |
| Float 8 | 9.94M |
| % Held by Insiders 1 | 84.73% |
| % Held by Institutions 1 | 2.96% |
| Shares Short (Jan 31, 2017) 4 | 89.85k |
| Short Ratio (Jan 31, 2017) 4 | 0.73 |
| Short % of Float (Jan 31, 2017) 4 | 1.20% |
| Short % of Shares Outstanding (Jan 31, 2017) 4 | 0.76% |
| Shares Short (prior month Dec 30, 2016) 4 | 76k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:5 |
| Last Split Date 3 | Aug 28, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2021 |
| Most Recent Quarter (mrq) | Dec 31, 2021 |
Profitability
| Profit Margin | -56.24% |
| Operating Margin (ttm) | -658.33% |
Management Effectiveness
| Return on Assets (ttm) | -58.46% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.56M |
| Revenue Per Share (ttm) | 0.03 |
| Quarterly Revenue Growth (yoy) | -95.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1.14M |
| Net Income Avi to Common (ttm) | -879k |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 150k |
| Total Debt/Equity (mrq) | 84.27% |
| Current Ratio (mrq) | 0.72 |
| Book Value Per Share (mrq) | 0.00 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -742k |
| Levered Free Cash Flow (ttm) | -1.1M |
© 2024 Yahoo. All rights reserved.